Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
QuintilesIMS
US Department of Justice
Boehringer Ingelheim
US Army
Teva
UBS
Johnson and Johnson
Accenture
Fish and Richardson

Generated: January 22, 2018

DrugPatentWatch Database Preview

Pseudoephedrine hydrochloride; triprolidine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for pseudoephedrine hydrochloride; triprolidine hydrochloride and what is the scope of pseudoephedrine hydrochloride; triprolidine hydrochloride freedom to operate?

Pseudoephedrine hydrochloride; triprolidine hydrochloride
is the generic ingredient in twelve branded drugs marketed by Glaxosmithkline, Kv Pharm, Cenci, Usl Pharma, Newtron Pharms, Pvt Form, Sandoz, Teva, Watson Labs, West Ward, Ivax Sub Teva Pharms, and Superpharm, and is included in sixteen NDAs. Additional information is available in the individual branded drug profile pages.

There are forty-nine drug master file entries for pseudoephedrine hydrochloride; triprolidine hydrochloride.
Summary for pseudoephedrine hydrochloride; triprolidine hydrochloride

US Patents and Regulatory Information for pseudoephedrine hydrochloride; triprolidine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ivax Sub Teva Pharms TRIPROLIDINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE pseudoephedrine hydrochloride; triprolidine hydrochloride TABLET;ORAL 085273-001 Dec 12, 1984 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz PSEUDOEPHEDRINE HYDROCHLORIDE AND TRIPROLIDINE HYDROCHLORIDE pseudoephedrine hydrochloride; triprolidine hydrochloride TABLET;ORAL 088193-001 May 17, 1983 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Usl Pharma MYFED pseudoephedrine hydrochloride; triprolidine hydrochloride SYRUP;ORAL 088116-001 Mar 4, 1983 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Cenci ACTAHIST pseudoephedrine hydrochloride; triprolidine hydrochloride SYRUP;ORAL 088344-001 Feb 9, 1984 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
West Ward TRIPROLIDINE AND PSEUDOEPHEDRINE pseudoephedrine hydrochloride; triprolidine hydrochloride TABLET;ORAL 088117-001 Apr 19, 1983 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz CORPHED pseudoephedrine hydrochloride; triprolidine hydrochloride TABLET;ORAL 088602-001 Apr 11, 1985 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Cenci HISTAFED pseudoephedrine hydrochloride; triprolidine hydrochloride SYRUP;ORAL 088283-001 Apr 20, 1984 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Glaxosmithkline ACTIFED pseudoephedrine hydrochloride; triprolidine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 018996-001 Jun 17, 1985 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Superpharm TRIPROLIDINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE pseudoephedrine hydrochloride; triprolidine hydrochloride TABLET;ORAL 088578-001 Feb 21, 1985 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs TRIPROLIDINE AND PSEUDOEPHEDRINE pseudoephedrine hydrochloride; triprolidine hydrochloride TABLET;ORAL 088318-002 Jan 13, 1984 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chubb
Boehringer Ingelheim
US Army
Argus Health
Moodys
Colorcon
Queensland Health
Chinese Patent Office
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot